GRANT APPLICATIONS – NOW OPEN

3D Muscle Printing Biotech Tender The Foundation, in the capacity of founding investor, would like to provide seed capital towards the establishment of an early stage biotech company which would be directed at the development of technology to build new muscle tissue suitable for transplant into FSHD sufferers specifically, [...]

GRANT APPLICATIONS – NOW OPEN2019-10-02T18:12:47+10:00

START THE NEW YEAR WITH A SPLASH WITH OUR NEW CEO KATE

Join us in the Cole Classic 1km Swim this February! Join our new CEO Kate as she takes to the seas with a team of FSHD champions to raise funds for FSHD Global on 4th February 2018 at the Cole Classic Ocean Swim at Manly. As the perfect ocean swim [...]

START THE NEW YEAR WITH A SPLASH WITH OUR NEW CEO KATE2019-10-02T18:12:47+10:00

READING THE SCIENCE

How to tell the good from the not so good. There are literally thousands of scientific articles published every year around the world by research groups. Inevitably some will be great and others will not. Even a trained scientist can find interpreting research difficult especially with so many studies [...]

READING THE SCIENCE2019-10-02T18:12:49+10:00

FACIO-THERAPIES ANNOUNCE BREAKTHROUGH

Facio-therapies recently announced a breakthrough development in FSHD drug discovery. What is it? Facio-therapies have developed a high through-put screening platform that uses muscle cells from people with FSHD and actually measures DUX4 protein levels. Why is it a breakthrough? Most screening platforms use cells that are not specific [...]

FACIO-THERAPIES ANNOUNCE BREAKTHROUGH2019-10-02T18:12:50+10:00

A NEW MECHANISM FOR FSHD

New drug targets FSHD is a progressive muscle wasting disease caused by a genetic mutation on chromosome 4 where a reduction in the number of repeated units in what is called the D4Z4 region, or mutations in a gene called SMCHD1, leads to the expression of a toxic gene [...]

A NEW MECHANISM FOR FSHD2020-03-16T15:29:48+10:00

FSHD GLOBAL PUBLISHES CLINICAL PRACTICE CONSIDERATIONS FOR FSHD

FSHD Global publishes clinical practice considerations for FSHD Clinical practice guidelines are an important part of clinical practice for many health professionals. Health professionals need to know about, understand and critically appraise new evidence as it becomes available. The problem facing many health professionals is the pace at which [...]

FSHD GLOBAL PUBLISHES CLINICAL PRACTICE CONSIDERATIONS FOR FSHD2019-10-02T18:12:50+10:00

FSHD : IT’S NOT ALL JUST ABOUT MUSCLES.

FSHD: It's not just about muscles. For people with FSHD it will come as no surprise that this condition effects more than just muscles. Progressive muscle weakness leads to massive changes in the way people live their lives impacting how they get around, how they complete daily activities, whether [...]

FSHD : IT’S NOT ALL JUST ABOUT MUSCLES.2020-03-16T15:36:27+10:00

CRISPR & FSHD

Harnessing a New Technology CRISPR is a technology that researchers have been embracing with enthusiasm all over the world. Our recent article Altering Gene Expression gives a brief overview of what CRISPR is and how it works. Essentially CRISPR is a way of making targeted changes in the genome or modulating [...]

CRISPR & FSHD2019-10-02T18:12:51+10:00

Title

Go to Top